Chaikitmongkol, Voraporn
Nanegrungsunk, Onnisa
Patikulsila, Direk
Choovuthayakorn, Janejit
Watanachai, Nawat
Kunavisarut, Paradee
Ittipunkul, Nimitr
Bressler, Neil M.
Article History
Received: 8 February 2018
Revised: 26 April 2018
Accepted: 7 May 2018
First Online: 14 August 2018
Compliance with ethical standards
:
: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. VC reported receiving research grant from Bayer and ThromboGenics; and receiving honoraria and travel reimbursement from Allergan and Novartis. ON reported no financial disclosure. DP reported working as a consultant, receiving honoraria and travel reimbursement from Bayer and Novartis; and receiving honoraria and travel reimbursement from Alcon. JC and NW reported receiving honoraria and travel reimbursement from Alcon, Allergan, Bayer and Novartis. PK reported receiving honoraria and travel reimbursement from Novartis. NI reported no financial disclosure. NMB reported receiving grants to employer, Johns Hopkins University; and from Bayer, Novartis, Roche (Genentech) and Samsung. No other disclosures were reported.